Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
Phase 3 Unknown
276 enrolled
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Phase 3 Unknown
350 enrolled
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Phase 3 Unknown
3,400 enrolled
Quality of Life in Patients With Bladder Cancer
Unknown
2,700 enrolled
Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
Phase 3 Unknown
515 enrolled
Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer
Unknown
1,600 enrolled
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
20 enrolled
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
Phase NA Unknown
120 enrolled
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Phase 1/2 Unknown
37 enrolled
UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer
Phase 2 Unknown
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
Phase NA Unknown
35 enrolled
Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
Phase 2 Unknown
14 enrolled
Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Phase 2 Unknown
14 enrolled
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Phase 1 Unknown
12 enrolled
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Phase 2 Unknown
17 enrolled
SU006668 in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
Phase 2 Unknown
Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
28 enrolled
Lymphocyte Therapy in Treating Patients With Kidney Cancer
Phase 2 Unknown
90 enrolled
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
Phase 2 Unknown
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Phase 1 Unknown
20 enrolled
Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
Phase 2 Unknown
35 enrolled
Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
Phase 1/2 Unknown
64 enrolled
Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
Phase 2 Unknown
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2 Unknown
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery
Phase 2 Unknown
20 enrolled
Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically
Phase 2 Unknown
30 enrolled
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Phase 3 Unknown
300 enrolled
Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
Phase 1/2 Unknown
35 enrolled
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Phase 2 Unknown
18 enrolled
Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 1 Unknown
Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
Phase 1 Unknown
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
Phase 2 Unknown
80 enrolled
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
Phase NA Unknown
50 enrolled
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
Phase 2 Unknown
800 enrolled
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
Phase 3 Unknown
105 enrolled
Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors
Phase NA Unknown
100 enrolled
Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners
Phase NA Unknown
100 enrolled
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
Phase 3 Unknown
900 enrolled
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Phase 3 Unknown
396 enrolled
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Phase NA Unknown
2,200 enrolled
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
14,000 enrolled
Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer
Phase 1 Unknown
198 enrolled
Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
Unknown
21,000 enrolled
High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer
Phase 2 Unknown
26 enrolled
3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder
Phase 1 Unknown
60 enrolled
Study of Treatment Choice in Patients With Localized Prostate Cancer
Phase NA Unknown
432 enrolled
Dutasteride in Treating Patients With Prostate Cancer
Phase 2 Unknown
42 enrolled
Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01
Unknown
60 enrolled
Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer
Phase 2 Unknown
110 enrolled